Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
12.6%
% of IYH's 107 holdings also in MEDX
43.3%
% of MEDX's 30 holdings also in IYH
Overlap by Weight
Sector Drift (IYH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IYH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.0% | 16.0% | 13.0% |
|
ABBVIE INC | 5.4% | 7.4% | 5.4% |
|
MERCK & CO. INC. | 5.7% | 4.7% | 4.7% |
|
JOHNSON & JOHNSON | 6.6% | 4.4% | 4.4% |
|
AMGEN INC | 3.2% | 6.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
IYH Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 9.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
ABBOTT LABORATORIES | 3.1% |
|
DANAHER CORP | 2.9% |
|
INTUITIVE SURGICAL INC | 2.9% |
|
VERTEX PHARMACEUTICALS INC | 2.3% |
|
JOHNSON & JOHNSON | 2.2% |
|
STRYKER CORP | 2.2% |
|
ELEVANCE HEALTH INC | 2.1% |
|
BOSTON SCIENTIFIC CORP | 2.0% |
IYH Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -5.7% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.5% |
|
BIOGEN IDEC INC | -3.3% |
|
ALNYLAM PHARMACEUTICALS INC | -3.3% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
IONIS PHARMACEUTICALS, INC. | -3.2% |
 |
ALKERMES PLC | -3.2% |
|
ELI LILLY & CO | -3.0% |
|
AMGEN INC | -3.0% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |